Skip to Content

Avapritinib (Ayvakit®) Management for Advanced Systemic Mastocytosis

Download PQI pdf 0.17MB

Last Updated: April 29, 2024

By: Andrew Kuykendall, MD | Katherine Tobon, PharmD, BCOP | Syeda Saba Kareem PharmD, BCOP

About this PQI

This PQI will discuss the initiation and management of patients receiving avapritinib for Advanced Systemic Mastocytosis (AdvSM).

How to Use a Positive Quality Intervention (PQI)

Essentially, it’s a tool to improve patient care by sharing best practices in oncology care. Consider this standardized, peer-review clinical guidance to oncology healthcare teams, enabling you and your team to consistently deliver high-quality care to your patients.

Find a PQI